Putting "sticky notes" on the electronic medical record to promote intra-hospital referral of hepatitis B and C virus-positive patients to hepatology specialists: an exploratory study

被引:17
作者
Fujii, Hideki [1 ]
Yamaguchi, Seiko [1 ]
Kurai, Osamu [1 ]
Miyano, Masato [1 ]
Ueda, Wataru [1 ]
Oba, Hiroko [1 ]
Aoki, Tetsuya [1 ]
Enomoto, Masaru [2 ]
Kawada, Norifumi [2 ]
Okawa, Kiyotaka [1 ]
机构
[1] Osaka City Juso Hosp, Dept Gastroenterol & Hepatol, Yodogawa Ku, Osaka 5320034, Japan
[2] Osaka City Univ, Grad Sch Med, Dept Hepatol, Abeno Ku, Osaka 5458585, Japan
基金
日本学术振兴会;
关键词
Hepatitis B virus; Hepatitis C virus; Screening; Intra-hospital referral; HEPATOCELLULAR-CARCINOMA;
D O I
10.1186/s12879-016-1765-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Currently, no system for appropriate intra-hospital collaboration regarding hepatitis virus positive individuals exists, even in medical institutions with hepatologists among their staff. The main objective of this study was to explore a simple alert system to promote the referral of patients with hepatitis B surface antigen (HBsAg)- or anti-hepatitis C virus (HCV) antibodies positivity to hepatologists through electronic medical records. Methods: Since April 2014 at Osaka City Juso Hospital, "sticky notes" have been put on the electronic medical records of patients newly diagnosed with HBsAg- or anti-HCV- antibodies positivity to recommend intra-hospital referral of those patients to specialists. In this study, we investigated the number of referrals to hepatologists before vs. after the introduction of this system (that is, in fiscal years 2013 [Period 1] and 2014 [Period 2], respectively), and the subsequent clinical courses of the patients. Results: The proportions of patients with HBsAg and anti-HCV antibody positivity did not show statistically significant differences between Period 1 and Period 2 (1.6 % [43/2,757] vs. 1.3 % [39/2,891], p = 0.58; and 5.8 % [156/2,674] vs. 5.3 % [147/2,790], p = 0.39, respectively). However, the referral proportions for patients with HBsAg- and anti-HCV antibody positivity were significantly higher in Period 2 (73 % [11/15] and 65 % [41/63], respectively) than in Period 1 (28 % [5/18] and 17 % [9/54]) (p = 0.009 and p < 0.001, respectively). Among patients who were referred to hepatologists, 2 HBsAg- positive and 4 anti-HCV antibody positive patients initiated antiviral treatment. Conclusion: Our simple electronic medical record based alert system effectively promoted intra-hospital referral of hepatitis virus-positive patients, who have been detected by screening tests, to hepatologists.
引用
收藏
页数:6
相关论文
共 18 条
[1]   HbA1c as a screening tool for detection of Type 2 diabetes:: a systematic review [J].
Bennett, C. M. ;
Guo, M. ;
Dharmage, S. C. .
DIABETIC MEDICINE, 2007, 24 (04) :333-343
[2]  
Furukawa N., 2013, KANZO, V54, P307, DOI [DOI 10.2957/KANZO.54.307, 10.2957/kanzo.54.307]
[3]   Outcomes of a hepatitis c screening program at a large urban VA Medical Center [J].
Groom, Holly ;
Dieperink, Eric ;
Nelson, David B. ;
Garrard, Judith ;
Johnson, James R. ;
Ewing, Stephen L. ;
Stockley, Herbert ;
Durfee, Janet ;
Jonk, Yvonne ;
Willenbring, Mark L. ;
Ho, Samuel B. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (01) :97-106
[4]   Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection [J].
Hosaka, Tetsuya ;
Suzuki, Fumitaka ;
Kobayashi, Masahiro ;
Seko, Yuya ;
Kawamura, Yusuke ;
Sezaki, Hitomi ;
Akuta, Norio ;
Suzuki, Yoshiyuki ;
Saitoh, Satoshi ;
Arase, Yasuji ;
Ikeda, Kenji ;
Kobayashi, Mariko ;
Kumada, Hiromitsu .
HEPATOLOGY, 2013, 58 (01) :98-107
[5]   Lamivudine for patients with chronic hepatitis B and advanced liver disease [J].
Liaw, YF ;
Sung, JJY ;
Chow, WC ;
Farrell, G ;
Lee, CZ ;
Yuen, H ;
Tanwandee, T ;
Tao, QM ;
Shue, K ;
Keene, ON ;
Dixon, JS ;
Gray, DF ;
Sabbat, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1521-1531
[6]   Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of Asians in California [J].
Lin, Steven Y. ;
Chang, Ellen T. ;
So, Samuel K. .
HEPATOLOGY, 2007, 46 (04) :1034-1040
[7]   Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C [J].
Lok, Anna S. ;
Everhart, James E. ;
Wright, Elizabeth C. ;
Di Bisceglie, Adrian M. ;
Kim, Hae-Young ;
Sterling, Richard K. ;
Everson, Gregory T. ;
Lindsay, Karen L. ;
Lee, William M. ;
Bonkovsky, Herbert L. ;
Dienstag, Jules L. ;
Ghany, Marc G. ;
Morishima, Chihiro ;
Morgan, Timothy R. .
GASTROENTEROLOGY, 2011, 140 (03) :840-U230
[8]   Institute of Medicine Recommendations for The Prevention and Control of Hepatitis B and C [J].
Mitchell, Abigail E. ;
Colvin, Heather M. ;
Beasley, R. Palmer .
HEPATOLOGY, 2010, 51 (03) :729-733
[9]   EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection [J].
Papatheodoridis, George ;
Buti, Maria ;
Cornberg, Markus ;
Janssen, Harry ;
Mutimer, David ;
Pol, Stanislas ;
Raimondo, Giovanni .
JOURNAL OF HEPATOLOGY, 2012, 57 (01) :167-185
[10]  
Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025